Beom‐Seok Yang - Concepedia

Author

Beom‐Seok Yang

Korea Institute of Science and Technology

Also Known As

B.-S. Yang, Beom-Seok YANG, Beom-Seok Yang, Beom‐Seok Yang

Publications

336

Citations

H-Index

Concepts

All Affiliations

Korea Institute of Science and Technology Korea University Korea Institute of Fusion Energy Korea University of Science and Technology Yonsei University

About

Beom‐Seok Yang is an author at Korea Institute of Science and Technology specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	189
2	Biochemistry	5	5	155
3	Natural Sciences	4	4	145
4	Cell Biology	4	4	56
5	Biomolecular Engineering	1	1	14

Beom‐Seok Yang

Publications

322

Citations

H-Index

Page 1

	Year	Citations
Synthesis and biological evaluations of pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 inhibitors Dong Chan Kim, Yeo Ran Lee, Beom‐Seok Yang, European Journal of Medicinal Chemistry Cyclin-dependent Kinase 2Bioorganic ChemistryBiochemistryBiological EvaluationsMedicine	2003	101
LCB 03-0110, a Novel Pan-Discoidin Domain Receptor/c-Src Family Tyrosine Kinase Inhibitor, Suppresses Scar Formation by Inhibiting Fibroblast and Macrophage Activation Xiaoyan Sun, Trong-Nhat Phan, Seung Hee Jung, Journal of Pharmacology and Experimental Therapeutics	2011	37
Single nucleotide polymorphisms in fibroblast growth factor 23 gene, <i> <scp>FGF</scp> 23 </i> , are associated with prostate cancer risk Hae Jong Kim, Kyeoung‐Hwa Kim, Jaehyouk Lee, British Journal of Urology	2013	31
Actinomycin D Identified as an Inhibitor of Discoidin Domain Receptor 2 Interaction with Collagen through an Insect Cell Based Screening of a Drug Compound Library Kauser Siddiqui, Geun Woong Kim, Dong Hoon Lee, Biological and Pharmaceutical Bulletin	2009	29
Quercetin Shows the Pharmacological Activity to Simultaneously Downregulate the Inflammatory and Fibrotic Responses to Tissue Injury in Association with its Ability to Target Multi-Kinases Ju-Yong Song, Do Vinh Truong, Beom‐Seok Yang Pharmacology	2018	23
1,4-Dioxane-fused 4-anilinoquinazoline as inhibitors of epidermal growth factor receptor kinase Jae Yeol Lee, Yong Kyu Park, Seon Hee Seo, Archiv der Pharmazie Molecular PharmacologyMedicinal ChemistryMedicinePd 1530354-Anilinoquinazoline Pd 153035	2001	21
Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A Dong‐Myung Kim, Kyungmi Yang, Beom‐Seok Yang Experimental & Molecular Medicine Molecular RegulationMolecular BiologyCell CycleCellular PhysiologyMolecular Characterization	2003	19
Low Stability and a Conserved<i>N</i>-Glycosylation Site Are Associated with Regulation of the Discoidin Domain Receptor Family by Glucose<i>via</i>Post-Translational<i>N</i>-Glycosylation Trong-Nhat Phan, Ee Lin Wong, Xiaoyan Sun, Bioscience Biotechnology and Biochemistry Ddr FamilyGlycobiologyMolecular BiologyDiscoidin Domain ReceptorReceptor Tyrosine Kinase	2013	14
Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice Sung Ha Jung, Xiaoyan Sun, Wang‐Shick Ryu, British Journal of Dermatology	2012	13
Anti‐angiogenic activity of thienopyridine derivative <scp>LCB</scp>03‐0110 by targeting <scp>VEGFR</scp>‐2 and <scp>JAK</scp>/<scp>STAT</scp>3 Signalling Byung‐Hak Kim, Yoonji Lee, Hyun Seung Yoo, Experimental Dermatology Chemoprevention StrategyPharmacotherapyTumor BiologyTumor AngiogenesisMolecular Pharmacology	2015	13

Page 1